중남미의 점안약 시장 예측(-2030년) : 지역별 분석 - 유형별, 용도별, 구입 방법별

The South & Central America eye drops market is expected to grow from US$ 1,017.09 million in 2022 to US$ 1,439.20 million by 2030. It is estimated to grow at a CAGR of 4.4% from 2022 to 2030.

Rising Initiatives for Eye Care Fuels South & Central America Eye Drops Market

In recent years, various measures and efforts have been taken to create awareness and educate people regarding eye diseases, prompting patients to access suitable medications and treatments. For instance, TeleOftalmo is a Brazilian project that offers telemedicine ophthalmology services to improve population access to diagnosis. Also, some pharmaceutical companies are launching projects to provide the general population with access to eye care. For example, Bayer collaborated with the local government to increase access to treatment and develop new eye care centers in a variety of places throughout Brazil, from large cities to rural communities. Furthermore, Argentina's ROP project is an example of a successful integrated eye care initiative led by the Ministry of Health's mother and child health program that has been effectively established throughout the health and legal systems. Such initiatives for eye care will likely offer growth opportunities to the eye drop market players.

South & Central America Eye Drops Market Overview

The South & Central America eye drops market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil accounts for a major share of the market in this region. Moreover, it is projected to record the highest CAGR during the forecast period. The rising prevalence of dry eye disease and growing awareness about the benefits of eye drops for its treatment, coupled with developing healthcare facilities, contributes to the rapid growth of the South & Central America eye drops market in South & Central America. Brazil is the largest country in South & Central America, with a vast population. It holds significant potential for the South & Central America eye drops market as various conferences are held in the country for ophthalmology, which encourages exploring different technologies in this specialty. Various studies have been conducted to understand the causes of dry eye conditions. In 2020, Brazil had 30.1 million of the elderly population, representing ~14.3% of the total population. According to the Brazilian Institute of Geography and Statistics (IBGE) estimates (2019), the geriatric population would grow at a rate of 3.6% per year, compared to the 0.2% increase in the total population. As a result, the elderly population would reach 73.4 million by 2060, which will be equivalent to 32.2% of the overall population. These stats indicate significant opportunities for the South & Central America eye drops market with the possible rise in the incidence of age-related ophthalmic diseases.

South & Central America Eye Drops Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Eye Drops Market Segmentation

The South & Central America eye drops market is segmented into type, application, purchase mode, and country.

Based on type, the South & Central America eye drops market is segmented into antibiotics, artificial tears, hormones, and others. The antibiotics segment held the largest share of the South & Central America eye drops market in 2022.

Based on application, the South & Central America eye drops market is segmented into eye diseases, eye care, and others. The eye diseases segment held the largest share of the South & Central America eye drops market in 2022. The eye diseases segment is further segmented into dry eye, glaucoma, cataract, and others.

Based on purchase mode, the South & Central America eye drops market is segmented into OTC and prescription. The prescription segment held a larger share of the South & Central America eye drops market in 2022.

Based on country, the South & Central America eye drops market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America eye drops market in 2022.

AbbVie Inc, Alcon AG, Bausch & Lomb Inc, Pfizer Inc, and Rohto Pharmaceutical Co Ltd are some of the leading companies operating in the South & Central America eye drops market.

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America Eye Drops Market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the South & Central America Eye Drops Market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

Table of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. South & Central America Eye Drops Market Landscape

• 4.1 Overview
• 4.2 PEST Analysis
  • 4.2.1 South & Central America PEST Analysis
• 4.3 Pipeline Analysis

5. South & Central America Eye Drops Market - Key Industry Dynamics

• 5.1 Market Drivers
  • 5.1.1 Rising Prevalence of Ophthalmic Diseases
  • 5.1.2 High Incidence of Age-Related Eye Diseases
• 5.2 Market Restraints
  • 5.2.1 Product Recalls
• 5.3 Market Opportunities
  • 5.3.1 Rising Initiatives for Eye Care
• 5.4 Future Trends
  • 5.4.1 Changing Lifestyle
• 5.5 Impact Analysis

6. Eye Drops Market - South & Central Market Analysis

• 6.1 South & Central America Eye Drops Market Revenue (US$ Mn), 2022 - 2030

7. South & Central America Eye Drops Market - Revenue and Forecast to 2030 - by Type

• 7.1 Overview
• 7.2 South & Central America Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
• 7.3 Antibiotics
  • 7.3.1 Overview
  • 7.3.2 Antibiotics: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
• 7.4 Artificial Tears
  • 7.4.1 Overview
  • 7.4.2 Artificial Tears: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
• 7.5 Hormones
  • 7.5.1 Overview
  • 7.5.2 Hormones: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
• 7.6 Others
  • 7.6.1 Overview
  • 7.6.2 Others: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Eye Drops Market - Revenue and Forecast to 2030 - by Application

• 8.1 Overview
• 8.2 South & Central America Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
• 8.3 Eye Diseases
  • 8.3.1 Overview
  • 8.3.2 Eye Diseases: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.2.1 Dry Eye
      • 8.3.2.1.1 Overview
    • 8.3.2.2 Dry Eye: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.2.3 Glaucoma
      • 8.3.2.3.1 Overview
      • 8.3.2.3.2 Glaucoma: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.2.4 Cataract
      • 8.3.2.4.1 Overview
      • 8.3.2.4.2 Cataract: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.2.5 Others
      • 8.3.2.5.1 Overview
      • 8.3.2.5.2 Others: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
• 8.4 Eye Care
  • 8.4.1 Overview
  • 8.4.2 Eye Care: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
• 8.5 Others
  • 8.5.1 Overview
  • 8.5.2 Others: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Eye Drops Market - Revenue and Forecast to 2030 - by Purchase Mode

• 9.1 Overview
• 9.2 South & Central America Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
• 9.3 Prescription
  • 9.3.1 Overview
  • 9.3.2 Prescription: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
• 9.4 OTC
  • 9.4.1 Overview
  • 9.4.2 OTC: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Eye Drops Market - Revenue and Forecast to 2030 - Country Analysis

• 10.1 South & Central America Eye Drops Market
  • 10.1.1 Overview
  • 10.1.2 South & Central America Eye Drops Market Share by Country - 2022 & 2030, (%)
    • 10.1.2.1 Brazil: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.2.1.1 Overview
    • 10.1.2.2 Brazil: South & Central America Eye Drops Market- Revenue and Forecasts to 2030 (US$ Million)
      • 10.1.2.2.1 Brazil: South & Central America Eye Drops Market, by Type, 2020-2030 (US$ Million)
      • 10.1.2.2.2 Brazil: South & Central America Eye Drops Market, By Application, 2020-2030 (US$ Million)
      • 10.1.2.2.2.1 Brazil: South & Central America Eye Drops Market, for Eye Diseases by Application, 2020-2030 (US$ Million)
      • 10.1.2.2.3 Brazil: South & Central America Eye Drops Market, By Purchase Mode, 2020-2030 (US$ Million)
    • 10.1.2.3 Argentina: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.2.3.1 Overview
    • 10.1.2.4 Argentina: South & Central America Eye Drops Market- Revenue and Forecasts to 2030 (US$ Million)
      • 10.1.2.4.1 Argentina: South & Central America Eye Drops Market, by Type, 2020-2030 (US$ Million)
      • 10.1.2.4.2 Argentina: South & Central America Eye Drops Market, By Application, 2020-2030 (US$ Million)
      • 10.1.2.4.2.1 Argentina: South & Central America Eye Drops Market, for Eye Diseases by Application, 2020-2030 (US$ Million)
      • 10.1.2.4.3 Argentina: South & Central America Eye Drops Market, By Purchase Mode, 2020-2030 (US$ Million)
    • 10.1.2.5 Rest of South & Central America: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.2.5.1 Overview
    • 10.1.2.6 Rest of South & Central America: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.2.6.1 Rest of South & Central America: South & Central America Eye Drops Market, by Type, 2020-2030 (US$ Million)
      • 10.1.2.6.2 Rest of South & Central America: South & Central America Eye Drops Market, By Application, 2020-2030 (US$ Million)
      • 10.1.2.6.2.1 Rest of South & Central America: South & Central America Eye Drops Market, for Eye Diseases by Application, 2020-2030 (US$ Million)
      • 10.1.2.6.3 Rest of South & Central America: South & Central America Eye Drops Market, By Purchase Mode, 2020-2030 (US$ Million)

11. South & Central America Eye Drops Market-Industry Landscape

• 11.1 Overview
• 11.2 Growth Strategies in the Eye Drop Market (%)
• 11.3 Organic Developments
  • 11.3.1 Overview
• 11.4 Inorganic Developments
  • 11.4.1 Overview

12. Company Profiles

• 12.1 Alcon AG
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
• 12.2 Pfizer Inc
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
• 12.3 Rohto Pharmaceutical Co Ltd
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
• 12.4 AbbVie Inc
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
• 12.5 Bausch & Lomb Inc
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments

13. Appendix

• 13.1 About Us
• 13.2 Glossary of Terms